Volume : 11, Issue : 07, July – 2024

Title:

COMPARATIVE EVALUATION OF PERCENTAGE LABEL CLAIM OF DIFFERENT BRANDS OF MARKETED AMLODIPINE

Authors :

*Amritha. A, *Dileep.C. Babu, *Varsha Suresh, Mrs. Dhanya. S, Mr. Nishad V.M, Dr. R. Xavier Arulappa, Dr. Prasobh G.R

Abstract :

Presence of various brands of similar drug product at different rates creates a question of quality and therapeutic efficacy in the mind of consumer. The marketing practice to promote the brands also invites the confusion among the patients and market middleman. The comparative evaluation of quality parameters gives an idea of difference in therapeutic effectiveness of brands. This study was conducted to understand and analyse the variation in quality parameters of different brands of Amlodipine tablets available in market. In the present work an inexpensive, easy, mercurial, particular,sensible, reproducible, and spectroscopic method has been used for the estimation of amlodipine in pure drug and marketed tablet formulation. Analysis was carried out at 238nm for pure drug amlodipine as well as for amlodipine marketed tablet formulation. The main purpose of the investigation was to measure that how much percentage of drug present in marketed tablet formulation for the estimation of amlodipine besylate tablet and amlodipine pure drug using distilled water as a solvent.
Key Words: UV Spectroscopy, Amlodipine, Methodology,

Cite This Article:

Please cite this article in press Amritha.A et al., Comparative Evaluation Of Percentage Label Claim Of Different Brands Of Marketed Amlodipine, Indo Am. J. P. Sci, 2024; 11 (07).

Number of Downloads : 10

References:

1. Reynolds EF, editor. The Extra Pharmacopoeia. 31st ed. London: The Royal Pharmaceutical Society; 1996; 819-20.
2. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet. 2000; 356:1949-54.
3. Saravu K, Balasubramanian R. Near-fatal amlodipine poisoning. J Assoc Physicians India. 2004; 52:156-7.
4. Ostroumova OD, Kochetkov AI. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients with Hypertension]. Kardiologiia. 2016 Dec; 56(11):27-37.
5. Lee EY, Park JK, Lee W, Kim YK, Park CS, Giles JT, Park JW, Shin K, Lee JS, Song YW, Lee EB. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud’s phenomenon: a double-blind, randomized, cross-over study. Rheumatology (Oxford). 2014 Apr; 53(4):658-64.
6. Naveed S, Qamar F, Sarwer G. Percentage assay of metformin in different medium using UV- spectrophotometer. World Res J Org Chem. 2014;2(1):12-14.
7. Naveed S. Simple UV spectrophotometric assay of Atorvastatin API formulation and their comparative study. Glob J Med Res. 2014;14(2):35-38.
8. Naveed S, Qamar F. A simple assay of Esomeprazole using UV spectrophotometer. Glob J Pharm Res. 2014;3(2):1921-25.
9. Safila Naveed, Hina Qamar, Wardha Jawaid, Urooj Bokhari. Simple UV Spectrophotometric Assay of Amlodipine.American Journal of Chemistry and Application;2014 sept;1(4);66-69.
10. Kuriyama S, Tomonari H, Tokudome G, Horiguchi M, Hayashi H, Kobayashi H, Ishikawa M, Hosoya T. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy. Hypertens Res. 2002 Nov; 25(6):849-55.
11. Whiteley WN, Gupta AK, Godec T, Rostamian S, Whitehouse A, Mackay J, Sever PS. Long-Term Incidence of Stroke and Dementia in ASCOT. Stroke. 2021 Oct; 52(10):3088-3096.
12. Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. Amlodipine metabolism in human liver microtomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos. 2014 Feb; 42(2):245-9.
13. Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA. Prior Medications and the Cardiovascular Benefits from Combination Angiotensin-Converting Enzyme Inhibition plus Calcium Channel Blockade among High-Risk Hypertensive Patients. J Am Heart Assoc. 2018 Jan 04; 7(1)
14. Malha L, August P. Safety of Antihypertensive Medications in Pregnancy: Living with Uncertainty. J Am Heart Assoc. 2019 Aug 06; 8(15):e013495.